NIOXNiox Group
68.80GBp0.00%Mkt Cap: 314.73M $P/E: 34.40

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and poi…

Key Statistics

Company
Market Cap314.73M $
Enterprise Value291.97M $
Revenue (TTM)52.93M $
Gross Profit36.63M $
Net Income (TTM)7.61M $
Revenue/Share0.1283 USD
Last Price68.80 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees97
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)34.40
P/E (Forward)17.17
PEG
EV/EBITDA18.78
EV/Revenue5.52
P/S5.93
P/B4.23
EPS (TTM)0.02
EPS (Forward)0.04
52W Range
53.8463% of range77.60
52W High77.60 GBp
52W Low53.84 GBp
Profitability
Gross Margin69.20%
Oper. Margin20.85%
EBITDA Margin29.36%
Profit Margin14.37%
ROE10.36%
ROA9.19%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF16.74M $
CapEx (TTM)1.63M $
FCF Margin22.36%
FCF Yield3.76%
Net Debt-20.54M $
Net Debt/EBITDA-1.32
Balance Sheet
Debt/Equity0.01
Current Ratio3.81
Quick Ratio3.12
Book Value/Sh0.1620 GBp
Cash/Share0.0480 GBp
Dividends
Fwd Div Rate0.0200 GBp
Trail. Div Rate0.0160 GBp
Div. Yield2.25%
5Y Avg Yield
Payout Ratio76.22%
Ex-Div DateMay 21, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)81.20 GBp
Upside (mean)+18.0%
Target Range77.00 GBp86.00 GBp
GBp77.00+18.0% to meanGBp86.00
# Analysts5
Ownership
Shares Out.420.87M
Float329.29M
Insiders20.93%
Institutions65.74%
Technical
SMA 5060.55 (+13.6%)
SMA 20063.26 (+8.8%)
Beta-0.10
S&P 52W Chg18.16%
Avg Vol (30d)610.24K
Avg Vol (10d)373.97K
Technical Indicators
RSI (14)73.9
MACD2.0788
MACD Signal1.4261
MACD Hist.+0.6527
BB Upper68.82 GBp
BB Middle63.42 GBp
BB Lower58.01 GBp
BB Width17.04%
ATR (14)2.981 GBp
Vol Ratio (20d)0.57x